Arcturus Therapeutics Holdings, Inc. (ARCT)
7.67
+0.47
(+6.53%)
USD |
NASDAQ |
Dec 10, 16:00
7.63
-0.04
(-0.52%)
After-Hours: 20:00
Arcturus Therapeutics Holdings Cash from Investing (Quarterly): -0.1949M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | 8.867M |
| Perspective Therapeutics, Inc. | 13.99M |
| Novavax, Inc. | -136.53M |
| Sangamo Therapeutics, Inc. | -0.064M |
| Myomo, Inc. | 0.1897M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -19.60M |
| Cash from Financing (Quarterly) | 1.300M |
| Free Cash Flow | -61.54M |
| Free Cash Flow Per Share (Quarterly) | -0.7282 |
| Free Cash Flow to Equity (Quarterly) | -18.82M |
| Free Cash Flow to Firm (Quarterly) | -19.80M |
| Free Cash Flow Yield | -29.60% |